Age at Diagnosis and Breast Cancer Survival in Iran
暂无分享,去创建一个
L. Kiemeney | A. Verbeek | J. V. van Dijck | T. Feuth | M. Broeders | N. Rostami | F. A. Vostakolaei
[1] L. Kiemeney,et al. The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030. , 2013, Breast.
[2] A. Haghdoost,et al. Prevalence of Breast Cancer in a Defined Population of Iran , 2011, Iranian Red Crescent medical journal.
[3] J. Harford,et al. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. , 2011, The Lancet. Oncology.
[4] P. Pharoah,et al. Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England , 2011, British Journal of Cancer.
[5] C. Shimizu,et al. Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis. , 2011, Japanese journal of clinical oncology.
[6] W. Woodward,et al. The impact of age on outcome in early-stage breast cancer. , 2011, Seminars in radiation oncology.
[7] W. Han,et al. Age <40 Years is an Independent Prognostic Factor Predicting Inferior Overall Survival in Patients Treated with Breast Conservative Therapy , 2011, The breast journal.
[8] M. Hakama,et al. Loss-adjusted hospital and population-based survival of cancer patients. , 2011, IARC scientific publications.
[9] C. Sweeney,et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] L. Livi,et al. The impact of young age on breast cancer outcome. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] A. Kheradmand,et al. World Journal of Surgical Oncology Open Access Research Postmastectomy Locoregional Recurrence and Recurrence-free Survival in Breast Cancer Patients , 2022 .
[12] M. Karbakhsh,et al. Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[13] L. Holmberg,et al. Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment , 2009, PloS one.
[14] A. Miller,et al. Age Distribution of Breast Cancer in the Middle East, Implications for Screening , 2009, The breast journal.
[15] R. Omranipour,et al. Prevalence of ductal carcinoma insitu of the breast in Tehran university medical centers: evaluation of 2244 cases , 2009 .
[16] D. Jeffe,et al. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. , 2009, Journal of the American College of Surgeons.
[17] W. Han,et al. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer , 2009, Breast Cancer Research and Treatment.
[18] Seyed Mohsen Mousavi,et al. Cancer incidence and mortality in Iran. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] D. Reidpath,et al. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran , 2009, BMC Cancer.
[20] S. Franceschi,et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer , 2008, International journal of cancer.
[21] A. Nahvijou,et al. Outcome of breast cancer in Iran: a study of Tehran Cancer Registry data. , 2008, Asian Pacific journal of cancer prevention : APJCP.
[22] Ali Montazeri,et al. Breast Cancer in Iran: An Epidemiological Review , 2007, The breast journal.
[23] W. Han,et al. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Afrakhteh,et al. High Prevalence of HER‐2/neu Overexpression among Iranian Women with Breast Cancer: True or False? , 2006, The breast journal.
[25] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[26] G. Vlastos,et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001. , 2005, European journal of cancer.
[27] G. Turashvili,et al. Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[28] U. Jeschke,et al. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. , 2005, Anticancer research.
[29] G. Turashvili,et al. Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[30] Z. Aziz,et al. Socioeconomic status and breast cancer survival in Pakistani women. , 2004, JPMA. The Journal of the Pakistan Medical Association.
[31] Ali Montazeri,et al. Breast cancer in Iran: a survival analysis. , 2004, Asian Pacific journal of cancer prevention : APJCP.
[32] K. Chia,et al. Do younger female breast cancer patients have a poorer prognosis? Results from a population‐based survival analysis , 2004, International journal of cancer.
[33] Paul W Dickman,et al. Regression models for relative survival , 2004, Statistics in medicine.
[34] Marilie D. Gammon,et al. Breast cancers among very young premenopausal women (United States) , 2003, Cancer Causes & Control.
[35] A. Miller,et al. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size , 2004, Breast Cancer Research and Treatment.
[36] Ali Montazeri,et al. Risk factors for breast cancer in Iran: a case-control study , 2002, Breast Cancer Research.
[37] G. Hortobagyi,et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis , 2001, Cancer.
[38] G. Berglund,et al. Survival of women with breast cancer in relation to smoking. , 2000, The European journal of surgery = Acta chirurgica.
[39] M. Vercelli,et al. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. , 2000, Critical reviews in oncology/hematology.
[40] P. Andersen,et al. Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.
[41] J. Rodriguez-Sierra,et al. Younger women with breast carcinoma have a poorer prognosis than older women , 1996, Cancer.
[42] F. Ederer,et al. The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.